Ritonavir

Product NDC
65162-061
11-digit product format
651620061
Labeler code
65162
Product ID
65162-061_6afba378-b2d9-4ae4-b5b3-cc8811f551d1
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ritonavir
Dosage form
TABLET
Route
ORAL
Labeler
Amneal Pharmaceuticals LLC
Application
ANDA208890
Marketing category
ANDA
Marketing start
2018-09-21
Substance
RITONAVIR
Active strength
100 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ritonavir
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RITONAVIR100 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiO3J8G9O825
Rxcui900575

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1d2364f5-8b1e-7c9a-4518-7b359d95fa50Product name220250116
00d976a9-a12a-db3d-ac4e-27498af714cfProduct name520250115
7a5f5ac7-15c0-4d8b-bea4-b3b28cb83a8dProduct name120231023
c8f34825-48cd-e7db-4048-c3be840a9308Product name520230123
d1ee4fdb-1116-417b-8889-dc05571445b3Product name120160825
f8d26468-b1dc-49d8-a188-8b5d531405efProduct name120150731
0b1bb9d1-e628-4e7c-aada-fd6532257932Product name120150416
96979b26-bb9a-43d8-e3a6-d69b9e9f75e5Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65162-061-06Ritonavir60 in 1 BOTTLETABLET6024
65162-061-32Ritonavir360 in 1 BOTTLETABLET36024

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
65162-061-06EA - Each65162-061b1d2b7dc-466c-45bc-9140-e2a3f22d744a12018-11-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65162-061RITONAVIR TABLET [AMNEAL PHARMACEUTICALS LLC]24Current NDC, Legacy NDC, 2 package rows20241031_a32cb2e3-d4e5-4bbf-9d88-20b2b249e779.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
900575ritonavir 100 MG Oral TabletPSNa32cb2e3-d4e5-4bbf-9d88-20b2b249e77924
900575ritonavir 100 MG Oral TabletSCDa32cb2e3-d4e5-4bbf-9d88-20b2b249e77924

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
65162-061-066516200610660 TABLET in 1 BOTTLE (65162-061-06) 60 tablet2018-09-210000-00-00NoNoCurrent
65162-061-3265162006132360 TABLET in 1 BOTTLE (65162-061-32) 360 tablet2018-09-210000-00-00NoNoCurrent